Methylphenidate abuse and misuse in patients affected with a psychiatric disorder and a substance use disorder: a systematic review

CONCLUSION: MPH misuse and abuse are significant concerns in patients with psychiatric disorders and SUD. Risk factors include impulsivity, history of substance abuse, and access to prescription stimulants. Integrated therapeutic approaches and stricter prescription monitoring are recommended to mitigate misuse risks.

via https://pubmed.ncbi.nlm.nih.gov/39624511/?utm_source=no_user_agent&utm_medium=rss&utm_campaign=None&utm_content=1lqZ3NPYysePVKsoyz66mDSgu4veDGJwnUBS47TBQPoOuNZY5J&fc=None&ff=20241219011007&v=2.18.0.post9+e462414